In a clinical study utilizing proteomics-supported biomarker models, OPN emerged as a significant predictor of procedural AKI, along with diabetes history, the blood urea nitrogen-to-creatinine ratio, C-reactive protein, and additional factors. The gene discussed is SPP1; the disease is acute kidney injury.